Domain Informations
Psioxus.com lookup results from whois.register.it server:
- Domain created: 2010-11-26T12:54:12Z
- Domain updated: 2024-11-26T09:33:31Z
- Domain expires: 2030-11-26T12:54:12Z 4 Years, 314 Days left
- Website age: 15 Years, 51 Days
- Registrar Domain ID: 1627405757_DOMAIN_COM-VRSN
- Registrar Url: http://www.register.it
- Registrar WHOIS Server: whois.register.it
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +39.05520021555
- Name server:
- ANNA.NS.CLOUDFLARE.COM
- PLATO.NS.CLOUDFLARE.COM
Network
- inetnum : 23.236.48.0 - 23.236.63.255
- name : GOOGLE-CLOUD
- handle : NET-23-236-48-0-1
- status : Direct Allocation
- created : 2006-09-29
- changed : 2019-11-01
- desc : ** The IP addresses under this netblock are in use by Google Cloud customers **,Direct all copyright and legal complaints to,https://support.google.com/legal/go/report,Direct all spam and abuse complaints to,https://support.google.com/code/go/gce_abuse_report,For fastest response, use the relevant forms above.,Complaints can also be sent to the GC Abuse desk,([email protected]),but may have longer turnaround times.,Complaints sent to any other POC will be ignored.,*** The IP addresses under this Org-ID are in use by Google Cloud customers ***,Direct all copyright and legal complaints to,https://support.google.com/legal/go/report,Direct all spam and abuse complaints to,https://support.google.com/code/go/gce_abuse_report,For fastest response, use the relevant forms above.,Complaints can also be sent to the GC Abuse desk,([email protected]),but may have longer turnaround times.,Complaints sent to any other POC will be ignored.
Owner
- organization : Google LLC
- handle : GOOGL-2
- address : Array,Mountain View,CA,94043,US
Technical support
- handle : ZG39-ARIN
- name : Google LLC
- phone : +1-650-253-0000
- email : [email protected]
Abuse
- handle : GCABU-ARIN
- name : GC Abuse
- phone : +1-650-253-0000
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Timezone: America/Los_Angeles
Site Inspections
Port Scanner (IP: 23.236.62.147)
Spam Check (IP: 23.236.62.147)
Email address with psioxus.com
2. [email protected]
3. [email protected]
4. [email protected]
5. [email protected]
6. [email protected]
7. [email protected]
Recent Searched Sites
› 38.54.16.85 (1 seconds ago) / US
› Q.dd3691.com (1 seconds ago) / JP
› Psioxus.com (1 seconds ago) / US
› Sdc.kespodak.edu.ng (1 seconds ago) / US
› Nervecalmo.com (1 seconds ago) / US
› Atmparts-china.en.alibaba.com (1 seconds ago) / US
› Aidfunds.org (1 seconds ago) / TH
› Skorochtenie.online (1 seconds ago) / DK
› Secretosparacontar.org (2 seconds ago) / US
› Pernilleholmboe.dk (1 seconds ago) / DE
› Lana.gov.ly (0 seconds ago) / DE
› Boga-advies.nl (2 seconds ago) / NL
› Rent-a-bee.ch (3 seconds ago) / CH
› Aquabayrvpark.com (3 seconds ago) / US
› Globalforestry.eu (2 seconds ago) / FR
› Applipo.ne.jp (2 seconds ago) / JP
› 60.wowfan.net (4 seconds ago) / HK
› Sikni.store (3 seconds ago) / UA
› Novascholars.com.au (2 seconds ago) / US
› Epicgames.dev (1 seconds ago) / US
Websites Listing
We found Websites Listing below when search with psioxus.com on Search Engine
PsiOxus Therapeutics Home - PsiOxus Therapeutics
PsiOxus is a clinical stage oncology company pioneering systemic immune oncology products that drive sustained reprogramming of the tumor microenvironment to overcome the central challenge of resistance to therapy. Our validated T-SIGn® vector platform can deliver multiple transgene payloads that re-engineer both primary and metastatic tumors. We have a rapidly …
Psioxus.comPsioxus Therapeutics | Company Email | Telephone | Contact ...
Contact details (email, telephone numbers etc.) for Psioxus Therapeutics
Pharmacompass.comPSIOXUS THERAPEUTICS Email Format - Psioxus Therapeutics ...
General email format of the people working at Psioxus Therapeutics Website of the company : psioxus.com / Country : United Kingdom / Industry : sign up to find out / Size of the company : sign up to find out
Directory.email-verifier.ioPsiOxus Therapeutics Privacy Policy - PsiOxus Therapeutics
You may withdraw your consent given under this paragraph (in whole or in part) at any time by contacting [email protected] or write FAO The Data Protection Manager, PsiOxus Therapeutics, 4-10 The Quadrant, Abingdon Science Park, Barton Lane, Abingdon, OX14 3YS. The withdrawal of your consent shall not affect the lawfulness of processing based on consent before …
Psioxus.comDARREN PLUMB, , Psioxus Therapeutics
Professional Email of Darren Plumb: [email protected] . Test the validity of this email address. Professional Email of Darren Plumb: [email protected] . Test the validity of this email address. Professional Email of Darren Plumb: [email protected] . Test the validity of …
Directory.email-verifier.ioPsiOxus Therapeutics - FierceBiotech
2017-09-26 · PsiOxus thinks it has figured out how to systemically deliver viruses that only replicate in tumor cells. That turned heads at Bristol-Myers Squibb, which struck two deals with PsiOxus last year ...
Fiercebiotech.comPsiOxus Therapeutics Updates Agreement with Bristol Myers ...
2021-04-07 · PsiOxus Therapeutics, Ltd. (PsiOxus) today announced an updated agreement to advance its clinical collaboration with Bristol Myers Squibb (NYSE: BMY) to evaluate the safety, tolerability, and preliminary efficacy of PsiOxus’ tumor re-engineering platform, in combination with Bristol Myers Squibb’s PD-1 immune checkpoint inhibitor Opdivo ® (nivolumab) to treat a …
Ca.finance.yahoo.comNALINI MARINO (FORMERLY RASIAH), , Psioxus Therapeutics
Verify the professional email of NALINI MARINO (FORMERLY RASIAH), , Psioxus Therapeutics. Email-verifier.io : the best email verifier in the world. Email-verifier.io. Back to homepage Email-Verifier.io is the BEST email verifier in the world. Test us for free! First Name: Nalini ...
Directory.email-verifier.ioPsioxus Therapeutics Management | Psioxus Therapeutics ...
Psioxus Therapeutics employs 50 employees. The Psioxus Therapeutics management team includes John Beadle (Founding Chief Executive Officer), Tom Lillie (Chief Medical Officer), and Paul Cockle (Vice President Immunology). Get Contact Info for All Departments
Rocketreach.coPsiOxus Therapeutics Ltd Employee Details, Technology ...
Find useful insights on PsiOxus Therapeutics Ltd’s employee, technology stack, location, news alerts and more at Slintel. Use Slintel to connect with top decision-makers at PsiOxus Therapeutics Ltd.
Slintel.comBristol Myers Squibb - Bristol-Myers Squibb Signs ...
2016-12-20 · Bristol-Myers Squibb Company (NYSE: BMY) and PsiOxus Therapeutics, Ltd. (PsiOxus) today announced an agreement granting Bristol-Myers Squibb exclusive worldwide rights to NG-348, a pre-clinical stage, “armed” oncolytic virus with the goal of addressing solid tumors. The agreement is subject to clearance under the Hart-Scott-Rodino Antitrust …
News.bms.comPsiOxus and bluebird bio Present Novel Data Combining ...
2021-04-14 · Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support
Bloomberg.comPsiOxus Therapeutics Updates Agreement with Bristol Myers ...
2021-04-07 · Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support
Bloomberg.comPsiOxus Therapeutics updates agreement with Bristol-Myers ...
2021-04-07 · NG-641, is a tumor re-engineering product using PsiOxus’ proprietary Tumor-Specific Immuno-Gene Therapy (T-SIGn) platform based upon the enadenotucirev vector. NG- 641 is a systemically administered product that encodes for the tumor selective delivery of an anti-FAP / anti-CD3 bispecific, interferon alpha, CXCL9 and CXCL10. Fibroblast Activating Protein …
Investorvillage.comPsioxus Therapeutics Limited - onscope.com
Psioxus Therapeutics Limited. Royaume‑Uni : Quantité totale PI: 63: Rang # Quantité totale PI: 19 215 Note d'activité PI: 2,4/5.0 49 Rang # Activité PI: 14 382 Classe Nice dominante: Services scientifiques, technolo... Brevets. Marques ...
Onscope.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| dublinmintoffice.ie | myhost.ie | 26 Days |
| ratyng.com | godaddy.com | -3 Years, -315 Days |
| acmcae.com | tucows.com | -2 Years, -361 Days |
| angelhandsdentistry.com | fastdomain.com | -3 Years, -131 Days |
| jonathanbowden.org | domain.com | -2 Years, -314 Days |
| frontlineas.com | godaddy.com | -3 Years, -120 Days |
| klyingshi.com | godaddy.com | -3 Years, -239 Days |
| kifrs.com | hosting.kr | -3 Years, -22 Days |
| enime.moe | namecheap.com | -3 Years, -323 Days |
| masfirms.com | namecheap.com | -3 Years, -61 Days |